Clinical Microbiology Newsletter
Volume 32, Issue 1 , Pages 1-6, 1 January 2010

The Best Practices for Screening, Monitoring, and Diagnosis of Cytomegalovirus Disease, Part I

  • Tiziana Lazzarotto, Ph.D.

      Affiliations

    • Corresponding Author InformationMailing address: T. Lazzarotto, Ph.D., U.O. Microbiologia, Policlinico S. Orsola-Malpighi, Via Massarenti n. 9, 40138 Bologna, Italy. Tel.: +39.051.636.3360. Fax: +39.051.307397

Head of the Laboratory of Virology, Operative Unit of Clinical Microbiology, Department of Haematology, Oncology and Laboratory Medicine, St. Orsola Malpighi General Hospital, University of Bologna, Bologna, Italy

Abstract 

Human cytomegalovirus (CMV), a ubiquitous member of the herpesvirus family, is an important human pathogen. Infections are usually asymptomatic but can be associated with a wide spectrum of diseases, particularly in immunocompromised persons. Primary infection during pregnancy may result in congenital infection leading to severe damage of the fetus. Intrauterine primary infections are second only to Down's syndrome as a known cause of mental retardation. CMV infection in transplant recipients may cause different clinical syndromes in different groups of patients, and the severity of the infection parallels the degree of immunosuppression.

As infections are either asymptomatic or accompanied by symptoms that are not specific to CMV (such as fever and leukopenia), laboratory techniques are the sole means of diagnosing CMV infection. Diagnosis of CMV infection can be made directly by demonstration of the virus or virus components in clinical samples or indirectly through serology. Part I of this article reviews infections in immunocompromised patients and the various approaches to monitoring and laboratory diagnosis of CMV infection.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Editor's Note: Part II of this article will be published in the January 15, 2010 issue of CMN (Vol. 32, No. 2).

PII: S0196-4399(09)00059-2

doi:10.1016/j.clinmicnews.2009.12.001

Clinical Microbiology Newsletter
Volume 32, Issue 1 , Pages 1-6, 1 January 2010